We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
(+18%)
Cap. Flow
+$342M
Cap. Flow
% of AUM
1.85%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$163M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$137M |
| 3 |
Repligen
RGEN
|
+$104M |
| 4 |
Biogen
BIIB
|
+$104M |
| 5 |
Zoetis
ZTS
|
+$91.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$173M |
| 2 |
Agilent Technologies
A
|
+$137M |
| 3 |
Fidelity National Information Services
FIS
|
+$86.2M |
| 4 |
Adobe
ADBE
|
+$76.2M |
| 5 |
Keurig Dr Pepper
KDP
|
+$75.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.24% |
| 2 | Consumer Discretionary | 12.89% |
| 3 | Financials | 10.77% |
| 4 | Technology | 9.62% |
| 5 | Industrials | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Air Products & Chemicals
APD
$65.2B
| $1.99M | 0.01% |
7,286
-1,753
| -19% | -$494K |
|
952
Sensient Technologies
SXT
$5.32B
| $1.99M | 0.01% |
26,951
-344,187
| -93% | -$24M |
|
953
Titan Machinery
TITN
$469M
| $1.99M | 0.01% |
101,752
+48,226
| +90% | +$827K |
|
954
iShares MSCI Taiwan ETF
EWT
$9.99B
| $1.99M | 0.01% |
+37,441
| New | +$1.83M |
|
955
BeyondSpring
BYSI
$48.1M
| $1.98M | 0.01% |
162,320
+96,387
| +146% | +$1.27M |
|
956
PetMed Express
PETS
$42.1M
| $1.98M | 0.01% |
+61,767
| New | +$1.9M |
|
957
Banco Bilbao Vizcaya Argentaria
BBVA
$147B
| $1.96M | 0.01% |
396,852
+102,498
| +35% | +$394K |
|
|
NFC.WS
958
CALL
DELISTED
New Frontier Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at
NFC.WS
| $1.96M | 0.01% |
+227,898
| New | +$1.96M |
|
959
Primoris Services
PRIM
$4.64B
| $1.96M | 0.01% |
70,881
-103,575
| -59% | -$2.38M |
|
960
908 Devices
MASS
$293M
| $1.94M | 0.01% |
+34,079
| New | +$1.99M |
|
961
Rocket Pharmaceuticals
RCKT
$355M
| $1.94M | 0.01% |
+35,390
| New | +$1.29M |
|
962
Integer Holdings
ITGR
$3.38B
| $1.93M | 0.01% |
+23,797
| New | +$1.67M |
|
963
Utz Brands
UTZ
$1.25B
| $1.93M | 0.01% |
+87,484
| New | +$1.66M |
|
964
WisdomTree India Earnings Fund ETF
EPI
$2.03B
| $1.93M | 0.01% |
+65,979
| New | +$1.72M |
|
965
PUT
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
| $1.92M | 0.01% |
+65,100
| New | +$1.74M |
|
966
ADC Therapeutics
ADCT
$145M
| $1.91M | 0.01% |
59,567
-136,085
| -70% | -$4.46M |
|
967
Freshpet
FRPT
$2.92B
| $1.91M | 0.01% |
+13,433
| New | +$1.73M |
|
|
TSC
968
DELISTED
TriState Capital Holdings, Inc.
TSC
| $1.9M | 0.01% |
109,415
-15,022
| -12% | -$226K |
|
969
Agios Pharmaceuticals
AGIO
$2.2B
| $1.9M | 0.01% |
43,878
+4,285
| +11% | +$169K |
|
970
Align Technology
ALGN
$12B
| $1.9M | 0.01% |
+3,553
| New | +$1.6M |
|
971
LeMaitre Vascular
LMAT
$2.26B
| $1.9M | 0.01% |
46,894
+10,195
| +28% | +$364K |
|
972
Affiliated Managers Group
AMG
$9.61B
| $1.9M | 0.01% |
+18,655
| New | +$1.61M |
|
|
EVA
973
DELISTED
Enviva Inc.
EVA
| $1.89M | 0.01% |
41,545
-73,374
| -64% | -$3.2M |
|
974
Monro
MNRO
$529M
| $1.85M | 0.01% |
+34,785
| New | +$1.59M |
|
|
SRTAW
975
CALL
DELISTED
Strata Critical Medical Inc Warrants
SRTAW
| $1.85M | 0.01% |
+166,666
| New | +$219K |
|
Similar funds
Marshall Wace's Q4 2020 Portfolio in Review
As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
- Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
- Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
- Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
- Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
- Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
- Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.
Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.